Parenteral Drugs (India) Share Price
21 Aug, 2023 1:45 PM (IST)
Parenteral Drugs (India) Performance
- Today's Low
- ₹3
- Today's High
- ₹3
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹3
- Previous Close₹3
- Volume2,313
- 50 DMA₹3.50
- 100 DMA₹3.50
- 200 DMA₹3.70
Parenteral Drugs (India) Chart
Investment Returns
Smart Investing Starts Here Start SIP with Parenteral Drugs (India) for Steady Growth!
Parenteral Drugs (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -0.1
- PEG Ratio
- -0
- Market Cap Cr
- 9
- P/B Ratio
- -0
- Average True Range
- 0.2
- EPS
- -25.6
- Dividend Yield
- 0
- MACD Signal
- -0.2
- RSI
- 36.04
- MFI
- 3.73
Latest Stock News Updates
The positive listing of Sai Parenteral's shares defied the grey market trend, in which the counter traded almost flat.
- Business Standard
- 4 months 2 weeks ago
Noumed Pharmaceuticals is a supplier of private label over the counter products to pharmacy chains across Australia and New Zealand
- Business Line
- 8 months 2 weeks ago
According to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of Sub clause 16(k) of Para A of part A of Schedule III of Listing Regulations, we wish to inform you that the Hon''ble NCLT, Mumbai has approved the resolution plan in the matter of the Corporate Debtor namely Parenteral Drugs(India) Ltd. vide their order dated 16.01.2025 as enclosed hereunder
- BSE India
- 1 year 6 months ago
Parenteral Drugs (India) Financials
Parenteral Drugs (India) Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹3.20
- 50 Day
- ₹3.50
- 100 Day
- ₹3.50
- 200 Day
- ₹3.70
Resistance and Support
- R3 3.20
- R2 3.00
- R1 3.00
- S1 2.80
- S2 2.60
- S3 2.60
Parenteral Drugs (India) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2022-05-30 | Audited Results & Others | Inter alia, to consider : The shifting of registered office of the Company within local limits of the city. |
| 2022-02-14 | Quarterly Results | |
| 2022-02-02 | Others | inter alia, To consider appointment of Independent Director and to consider sale, lease or disposal of the whole or substantially the whole of the undertaking of the Company. |
| 2021-11-12 | Quarterly Results | |
| 2021-08-10 | Quarterly Results |
About Parenteral Drugs (India)
Parenteral Drugs (India) Company engaged primarily in the business of Manufacturing of Pharmaceutical Product. The Company is also engaged in trading in various products. View More- NSE Symbol
- PDPL
- BSE Symbol
- 524689
- Executive Director,Managing Director,Chief Financial Officer
- Vinod Kumar Gupta
- ISIN
- INE904D01019
Similar Stocks to Parenteral Drugs (India)
Popular Stocks
Parenteral Drugs (India) FAQs
Parenteral Drugs (India) share price is ₹2 As on 20 August, 2026 | 07:51
The Market Cap of Parenteral Drugs (India) is ₹8.6 Cr As on 20 August, 2026 | 07:51
The P/E ratio of Parenteral Drugs (India) is -0.1 As on 20 August, 2026 | 07:51
The PB ratio of Parenteral Drugs (India) is -0 As on 20 August, 2026 | 07:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.